|
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | XLRN  | Acceleron Pharma Inc | $1.1B | NASDAQ | 29.0909 |
 | ACRX  | AcelRx Pharmaceuticals Inc | $113.3M | NASDAQ | -1.5052 |
 | AKAO  | Achaogen Inc | $815.5M | NASDAQ | 7.1453 |
 | ACHN  | Achillion Pharmaceuticals, Inc. | $529.0M | NASDAQ | 22.5575 |
 | ACRS  | Aclaris Therapeutics Inc | $572.1M | NASDAQ | 58.3345 |
 | ACOR  | Acorda Therapeutics Inc | $732.6M | NASDAQ | 1.1994 |
 | ATNM  | Actinium Pharmaceuticals Inc | $78.0M | NYSE MKT | 3.049 |
 | ADAP  | Adaptimmune Therapeutics PLC - ADR | $278.1M | NASDAQ | 7.7877 |
 | ADMA  | ADMA Biologics Inc | $55.9M | NASDAQ | -4.111 |
 | ADRO  | Aduro BioTech Inc | $641.0M | NASDAQ | 2.4835 |
 | ADVM  | Adverum Biotechnologies Inc | $126.1M | NASDAQ | 4.7025 |
 | AGLE  | Aeglea Bio Therapeutics Inc | $84.5M | NASDAQ | 14.8602 |
 | AERI  | Aerie Pharmaceuticals Inc | $1.3B | NASDAQ | 6.0036 |
 | AFMD  | Affimed NV | $73.2M | NASDAQ | 6.7708 |
 | AGRX  | Agile Therapeutics Inc | $100.9M | NASDAQ | -1.1068 |
 | AGIO  | Agios Pharmaceuticals Inc | $2.0B | NASDAQ | 4.1239 |
 | AKTX  | Akari Therapeutics PLC (ADR) | $111.1M | NASDAQ | 7.983 |
 | AKBA  | Akebia Therapeutics Inc | $493.1M | NASDAQ | 0.2589 |
 | BIOD  | Albireo Pharma Inc | $41.7M | NASDAQ | -1.3011 |
 | ADHD  | Alcobra Ltd | $32.2M | NASDAQ | 2.878 |
 | ALDR  | Alder Biopharmaceuticals Inc | $913.3M | NASDAQ | 26.7271 |
 | ALDX  | Aldeyra Therapeutics Inc | $49.2M | NASDAQ | 6.0897 |
 | AMRN  | Amarin Corporation plc (ADR) | $553.0M | NASDAQ | -6.8407 |
 | AMGN  | Amgen, Inc. | $118.0B | NASDAQ | 2.4006 |
 | AMPE  | Ampio Pharmaceuticals Inc | $46.2M | NYSE MKT | -11.4887 |
 | ANTH  | Anthera Pharmaceuticals Inc | $21.4M | NASDAQ | -21.8026 |
 | AGTC  | Applied Genetic Technologies Corp | $104.8M | NASDAQ | 1.2366 |
| APVO  | Aptevo Therapeutics Inc | $41.9M | NASDAQ | 0.4018 |
 | ARDM  | Aradigm Corporation | $13.4M | NASDAQ | -23.0242 |
 | ARDX  | Ardelyx Inc | $353.1M | NASDAQ | 18.7908 |
 | ARIA  | Ariad Pharmaceuticals, Inc. | $4.7B | NASDAQ | -1.291 |
 | ARRY  | Array Biopharma Inc | $949.8M | NASDAQ | -3.6314 |
 | ARWR  | Arrowhead Pharmaceuticals Inc | $126.8M | NASDAQ | -2.0507 |
 | ASND  | Ascendis Pharma A/S | $508.9M | NASDAQ | 20.111 |
 | ATRA  | Atara Biotherapeutics Inc | $439.4M | NASDAQ | 34.2465 |
 | ATHX  | Athersys, Inc. | $166.9M | NASDAQ | -12.3547 |
 | BOLD  | Audentes Therapeutics Inc | $374.4M | NASDAQ | 12.2021 |
 | AUPH  | Aurinia Pharmaceuticals Inc | $602.5M | NASDAQ | |
 | EARS  | Auris Medical Holding AG | $24.1M | NASDAQ | -2.7241 |
 | AVEO  | AVEO Pharmaceuticals, Inc. | $43.2M | NASDAQ | -25.0621 |
 | AVXS  | AveXis Inc | $1.8B | NASDAQ | 42.6926 |
 | AVIR  | Aviragen Therapeutics Inc | $19.3M | NASDAQ | 0.0358 |
 | AXSM  | Axsome Therapeutics Inc | $79.5M | NASDAQ | 2.8133 |
 | BGNE  | Beigene Ltd (ADR) | $1.2B | NASDAQ | 13.9383 |
 | BLPH  | Bellerophon Therapeutics Inc | $51.8M | NASDAQ | -2.7278 |
 | BLCM  | Bellicum Pharmaceuticals Inc | $343.0M | NASDAQ | 7.4987 |
 | ORPN  | Bio Blast Pharma Ltd | $7.1M | NASDAQ | -0.0027 |
 | BCRX  | BioCryst Pharmaceuticals, Inc. | $431.1M | NASDAQ | -4.5137 |
| BPMX  | Biopharmx Corp | $31.4M | NYSE MKT | 8.4076 |
 | APPY  | Bioptix Inc | $17.7M | NASDAQ | -4.7044 |
 | BSTC  | BioSpecifics Technologies Corp. | $393.8M | NASDAQ | 27.4249 |
 | BSPM  | Biostar Pharmaceuticals Inc | $4.7M | NASDAQ | 0.764 |
 | BTX  | BioTime, Inc. | $329.8M | NYSE MKT | 6.2858 |
 | BLUE  | bluebird bio Inc | $3.3B | NASDAQ | 7.3333 |
 | CALA  | Calithera Biosciences Inc | $385.3M | NASDAQ | 34.0968 |
 | CAPR  | Capricor Therapeutics Inc | $24.8M | NASDAQ | -1.6106 |
 | CASC  | Cascadian Therapeutics Inc (USA) | $83.5M | NASDAQ | -3.4793 |
 | CATB  | Catabasis Pharmaceuticals Inc | $30.3M | NASDAQ | -2.4531 |
 | CPRX  | Catalyst Pharmaceuticals Inc | $161.6M | NASDAQ | 32.7198 |
 | CVM  | CEL-SCI Corporation | $23.8M | NYSE MKT | -33.5344 |
 | CELG  | Celgene Corporation | $92.5B | NASDAQ | 3.8583 |
 | CBMG  | Cellular Biomedicine Group Inc | $75.7M | NASDAQ | 34.1056 |
 | CLSN  | Celsion Corporation | $13.3M | NASDAQ | -10.7038 |
 | CEMP  | Cempra Inc | $1.3B | NASDAQ | 14.9979 |
 | CERU  | Cerulean Pharma Inc | $13.1M | NASDAQ | -6.3346 |
 | CMRX  | Chimerix Inc | $214.4M | NASDAQ | 15.4674 |
 | CBPO  | China Biologic Products Inc | $3.0B | NASDAQ | 13.5453 |
 | CDTX  | Cidara Therapeutics Inc | $122.6M | NASDAQ | 4.0432 |
 | CLSD  | Clearside Biomedical Inc | $184.7M | NASDAQ | 7.4973 |
 | CLVS  | Clovis Oncology Inc | $1.8B | NASDAQ | 0.261 |
 | CHRS  | Coherus Biosciences Inc | $969.5M | NASDAQ | 1.3776 |
 | CNAT  | Conatus Pharmaceuticals Inc | $114.0M | NASDAQ | -0.7108 |
 | CTRV  | ContraVir Pharmaceuticals Inc | $45.3M | NASDAQ | -2.7519 |
 | CRBP  | Corbus Pharmaceuticals Holdings Inc | $280.0M | NASDAQ | 26.6079 |
 | CYCCP  | Cyclacel Pharmaceuticals Inc | $21.8M | NASDAQ | 3.3066 |
 | CYCC  | Cyclacel Pharmaceuticals Inc | $22.9M | NASDAQ | 2.6598 |
 | CBAY  | CymaBay Therapeutics Inc | $92.4M | NASDAQ | -26.7117 |
| CYNA  | Cynapsus Therapeutics Inc | $504.0M | NASDAQ | |
 | CYTK  | Cytokinetics, Inc. | $571.7M | NASDAQ | 4.7096 |
 | CTMX  | CytomX Therapeutics Inc | $530.5M | NASDAQ | 2.4926 |
 | DERM  | Dermira Inc | $952.4M | NASDAQ | 12.1402 |
 | DMTX  | Dimension Therapeutics Inc | $31.3M | NASDAQ | 0.2063 |
 | DPRX  | Dipexium Pharmaceuticals Inc | $13.9M | NASDAQ | 0.3519 |
 | DRRX  | DURECT Corporation | $167.7M | NASDAQ | -12.3275 |
 | DVAX  | Dynavax Technologies Corporation | $259.1M | NASDAQ | -2.0352 |
 | EDGE  | Edge Therapeutics Inc | $302.0M | NASDAQ | 6.9849 |
 | EGLT  | Egalet Corp | $76.4M | NASDAQ | -1.2306 |
 | EBIO  | Eleven Biotherapeutics Inc | $34.1M | NASDAQ | -0.7155 |
 | ECYT  | Endocyte, Inc. | $122.5M | NASDAQ | 8.3951 |
 | EPZM  | Epizyme Inc | $947.6M | NASDAQ | 10.9035 |
 | EXEL  | Exelixis, Inc. | $5.0B | NASDAQ | 2.3489 |
 | FATE  | Fate Therapeutics Inc | $136.9M | NASDAQ | 2.9069 |
 | FPRX  | Five Prime Therapeutics Inc | $845.4M | NASDAQ | 13.8007 |
 | FLKS  | Flex Pharma Inc | $62.7M | NASDAQ | 11.2072 |
 | FLXN  | Flexion Therapeutics Inc | $613.3M | NASDAQ | 12.9415 |
 | FOMX  | Foamix Pharmaceuticals Ltd | $176.8M | NASDAQ | 32.5151 |
 | FWP  | Forward Pharma A/S | $820.2M | NASDAQ | 95.8399 |
 | GLMD  | Galmed Pharmaceuticals Ltd | $53.7M | NASDAQ | 1.42 |
 | GEMP  | Gemphire Therapeutics Inc | $92.6M | NASDAQ | 12.3594 |
 | GERN  | Geron Corporation | $456.7M | NASDAQ | 17.3178 |
 | GILD  | Gilead Sciences, Inc. | $86.5B | NASDAQ | 2.5416 |
 | GLYC  | GlycoMimetics Inc | $115.3M | NASDAQ | 9.6837 |
 | GWPH  | GW Pharmaceuticals PLC- ADR | $2.7B | NASDAQ | 26.0052 |
 | HALO  | Halozyme Therapeutics, Inc. | $1.8B | NASDAQ | 1.9375 |
 | HTBX  | Heat Biologics Inc | $19.1M | NASDAQ | 114.429 |
 | HEB  | Hemispherx BioPharma, Inc | $15.2M | NYSE MKT | -19.6925 |
 | RXDX  | Ignyta Inc | $277.0M | NASDAQ | 2.96 |
 | IMDZ  | Immune Design Corp | $125.1M | NASDAQ | 2.8413 |
 | IMMY  | Imprimis Pharmaceuticals Inc | $49.5M | NASDAQ | -1.4264 |
 | ITEK  | Inotek Pharmaceuticals Corp | $44.4M | NASDAQ | -0.8861 |
 | INSM  | Insmed Incorporated | $1.1B | NASDAQ | 3.5008 |
 | INSY  | Insys Therapeutics Inc | $835.6M | NASDAQ | 6.3789 |
 | NTEC  | Intec Pharma Ltd | $59.2M | NASDAQ | |
 | ICPT  | Intercept Pharmaceuticals Inc | $2.9B | NASDAQ | 3.3979 |
 | ITCI  | Intra-Cellular Therapies Inc | $488.9M | NASDAQ | 27.7963 |
 | JUNO  | Juno Therapeutics Inc | $2.6B | NASDAQ | 4.8317 |
 | KPTI  | Karyopharm Therapeutics Inc | $350.5M | NASDAQ | 10.2698 |
 | KMPH  | KemPharm Inc | $61.5M | NASDAQ | -0.6917 |
 | KERX  | Keryx Biopharmaceuticals | $692.6M | NASDAQ | -5.0524 |
 | KIN  | Kindred Biosciences Inc | $139.2M | NASDAQ | 17.7241 |
 | KITE  | Kite Pharma Inc | $3.7B | NASDAQ | 22.1616 |
 | KTOV  | Kitov Pharmaceuticals Holdings Ltd (ADR) | $13.2M | NASDAQ | |
 | KURA  | Kura Oncology Inc | $192.5M | NASDAQ | 8.7755 |
 | LJPC  | La Jolla Pharmaceutical Company | $626.6M | NASDAQ | 27.7499 |
 | LXRX  | Lexicon Pharmaceuticals, Inc. | $1.7B | NASDAQ | 0.0886 |
 | LPCN  | Lipocine Inc | $66.6M | NASDAQ | 32.8068 |
 | LOXO  | Loxo Oncology Inc | $938.7M | NASDAQ | 36.8295 |
 | MGNX  | MacroGenics Inc | $672.4M | NASDAQ | 9.9404 |
 | MDGL  | Madrigal Pharmaceuticals Inc | $180.3M | NASDAQ | 20.8068 |
 | MNKD  | MannKind Corporation | $99.4M | NASDAQ | -33.9723 |
 | MNOV  | MediciNova, Inc. | $188.9M | NASDAQ | 13.013 |
 | MDVN  | Medivation Inc | $13.5B | NASDAQ | 12.903 |
 | MEIP  | MEI Pharma Inc | $56.0M | NASDAQ | 2.4896 |
 | MRUS  | Merus NV | $293.6M | NASDAQ | 3.2226 |
 | STEM  | Microbot Medical Inc | $34.9M | NASDAQ | 13.3709 |
 | MTP  | Midatech Pharma PLC-ADR | $45.8M | NASDAQ | |
 | NERV  | Minerva Neurosciences Inc | $261.1M | NASDAQ | 5.158 |
 | MYOK  | Myokardia Inc | $378.3M | NASDAQ | 4.7542 |
| NBRV  | Nabriva Therapeutics AG - ADR | $20.5M | NASDAQ | 3.0281 |
 | NNVC  | NanoViricides Inc | $70.7M | NYSE MKT | 2.2466 |
 | NK  | Nantkwest Inc | $327.6M | NASDAQ | 5.9739 |
 | NBIX  | Neurocrine Biosciences, Inc. | $4.7B | NASDAQ | 42.5746 |
 | NDRM  | Neuroderm Ltd | $512.0M | NASDAQ | 51.9667 |
 | NVET  | Nexvet Biopharma plc | $78.8M | NASDAQ | 4.2072 |
 | NVLS  | Nivalis Therapeutics Inc | $37.3M | NASDAQ | 0.766 |
 | NVCR  | Novocure Ltd | $1.0B | NASDAQ | 1.2086 |
 | OMER  | Omeros Corporation | $574.5M | NASDAQ | -5.8199 |
 | OCX  | OncoCyte Corp | $148.8M | NYSE MKT | 16.7674 |
 | OPXA  | Opexa Therapeutics Inc | $4.1M | NASDAQ | -54.2446 |
 | OPHT  | Ophthotech Corp | $91.0M | NASDAQ | -1.511 |
 | OREX  | Orexigen Therapeutics, Inc. | $48.3M | NASDAQ | -2.1327 |
 | OTIC  | Otonomy Inc | $432.9M | NASDAQ | 14.2439 |
 | PTIE  | Pain Therapeutics, Inc. | $29.6M | NASDAQ | 14.1336 |
 | PRTK  | Paratek Pharmaceuticals Inc | $519.4M | NASDAQ | 0.5467 |
 | PFNX  | Pfenex Inc | $108.8M | NYSE MKT | 2.9622 |
 | PIP  | PharmAthene, Inc. | $44.7M | NYSE MKT | 0.0869 |
 | PZRX  | PhaseRx Inc | $14.5M | NASDAQ | -3.5955 |
 | PIRS  | Pieris Pharmaceuticals Inc | $163.6M | NASDAQ | 3.0137 |
 | PGNX  | Progenics Pharmaceuticals, Inc. | $502.5M | NASDAQ | 2.6491 |
 | DNAI  | ProNAi Therapeutics Inc | $41.9M | NASDAQ | -2.9808 |
 | PRQR  | ProQR Therapeutics NV | $119.1M | NASDAQ | 5.8256 |
 | PRTO  | Proteon Therapeutics Inc | $24.1M | NASDAQ | -0.6723 |
 | PTI  | Proteostasis Therapeutics Inc | $112.2M | NASDAQ | 9.3681 |
 | PRTA  | Prothena Corporation PLC | $1.9B | NASDAQ | 12.9503 |
 | PSDV  | pSivida Corp. | $71.1M | NASDAQ | -5.1667 |
 | PTCT  | PTC Therapeutics, Inc. | $218.8M | NASDAQ | 0.0452 |
 | PULM  | Pulmatrix Inc | $47.9M | NASDAQ | -8.3222 |
 | RDUS  | Radius Health Inc | $1.5B | NASDAQ | 31.2381 |
 | RPTP  | Raptor Pharmaceutical Corp. | $767.8M | NASDAQ | 0.6981 |
 | RETA  | Reata Pharmaceuticals Inc | $168.8M | NASDAQ | -3.1971 |
 | REPH  | Recro Pharma Inc | $78.1M | NASDAQ | 0.7724 |
 | REGN  | Regeneron Pharmaceuticals Inc | $45.7B | NASDAQ | 9.9971 |
 | RGNX  | Regenxbio Inc | $489.7M | NASDAQ | 28.2202 |
 | RLYP  | Relypsa Inc | $1.4B | NASDAQ | 7.6424 |
 | RTRX  | Retrophin Inc | $648.6M | NASDAQ | 2.6482 |
 | RVNC  | Revance Therapeutics Inc | $573.9M | NASDAQ | 10.2146 |
 | RNN  | Rexahn Pharmaceuticals, Inc. | $108.3M | NYSE MKT | 1.9979 |
 | RIGL  | Rigel Pharmaceuticals, Inc. | $265.1M | NASDAQ | -11.0436 |
 | RTTR  | Ritter Pharmaceuticals Inc | $5.3M | NASDAQ | -5.1429 |
 | SGMO  | Sangamo Therapeutics Inc | $589.9M | NASDAQ | 6.5227 |
 | SRPT  | Sarepta Therapeutics Inc | $1.9B | NASDAQ | 9.8924 |
 | MSTX  | Savara Inc | $33.1M | NYSE MKT | -21.7447 |
 | SELB  | Selecta Biosciences Inc | $245.7M | NASDAQ | 3.1259 |
 | MCRB  | Seres Therapeutics Inc | $403.1M | NASDAQ | 1.7972 |
 | SRNE  | Sorrento Therapeutics Inc | $86.5M | NASDAQ | -0.1225 |
 | ONCE  | Spark Therapeutics Inc | $1.8B | NASDAQ | 24.7571 |
 | SBPH  | Spring Bank Pharmaceuticals Inc | $86.8M | NASDAQ | 2.2332 |
 | STDY  | Steadymed Ltd | $141.5M | NASDAQ | 2.611 |
 | STML  | Stemline Therapeutics Inc | $206.7M | NASDAQ | 10.0875 |
 | SCMP  | Sucampo Pharmaceuticals, Inc. | $497.2M | NASDAQ | 1.9893 |
 | SMMT  | Summit Therapeutics PLC (ADR) | $134.1M | NASDAQ | |
 | SGYP  | Synergy Pharmaceuticals Inc | $777.0M | NASDAQ | 3.4429 |
 | SYN  | Synthetic Biologics Inc | $60.6M | NYSE MKT | -7.7179 |
 | TSRO  | TESARO Inc | $7.5B | NASDAQ | 23.8353 |
 | TBRA  | Tobira Therapeutics Inc | $462.0M | NASDAQ | -1.1323 |
 | TCON  | TRACON Pharmaceuticals Inc | $41.5M | NASDAQ | 0.1088 |
 | TRVN  | Trevena Inc | $184.5M | NASDAQ | 0.9872 |
 | RARE  | Ultragenyx Pharmaceutical Inc | $2.3B | NASDAQ | 26.8898 |
 | QURE  | Uniqure NV | $123.8M | NASDAQ | -1.3394 |
 | VNDA  | Vanda Pharmaceuticals Inc. | $627.6M | NASDAQ | 4.0202 |
 | VBLT  | Vascular Biogenics Ltd | $165.4M | NASDAQ | 15.3581 |
 | VSTM  | Verastem Inc | $90.6M | NASDAQ | 1.1239 |
 | VSAR  | Versartis Inc | $517.0M | NASDAQ | 8.1082 |
 | VRTX  | Vertex Pharmaceuticals Incorporated | $28.4B | NASDAQ | 9.4259 |
 | VICL  | Vical Incorporated | $25.0M | NASDAQ | -7.8404 |
 | VTL  | Vital Therapies Inc | $97.8M | NASDAQ | 10.4697 |
 | VTVT  | vTv Therapeutics Inc | $171.6M | NASDAQ | -3.8426 |
| XBIT  | XBiotech Inc | $313.7M | NASDAQ | 42.9047 |
 | XNCR  | Xencor Inc | $913.6M | NASDAQ | 5.1255 |
 | XENE  | Xenon Pharmaceuticals Inc | $75.6M | NASDAQ | 12.1138 |
 | XOMA  | XOMA Corp | $37.7M | NASDAQ | -19.2268 |
 | ZFGN  | Zafgen Inc | $112.9M | NASDAQ | 5.9543 |
 | ZIOP  | ZIOPHARM Oncology Inc. | $969.5M | NASDAQ | 0.6725 |
 | ZSAN  | Zosano Pharma Corp | $47.7M | NASDAQ | -11.7598 |